Literature DB >> 6981476

Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.

R K Mallya, D Vergani, D E Tee, L Bevis, F C de Beer, H Berry, E D Hamilton, B E Mace, M B Pepys.   

Abstract

The concentrations of C3d in the plasma and of C-reactive protein (CRP), immune complexes and rheumatoid factor in the serum were measured in 99 patients with rheumatoid arthritis. Most patients had raised levels, the values of which correlated with disease activity assessed according to a newly described index based on multivariate analysis of subjective, semi-objective and objective features of the disease. There were also significant correlations between the values for plasma C3d and circulating immune complexes, immune complexes and rheumatoid factor, serum CRP and immune complexes, and serum CRP and plasma C3d. Measurement of plasma C3d provides a useful means of detecting in vivo complement activation, which may be involved in the pathogenesis of rheumatoid arthritis, but neither C3d levels nor any of the other variables correlated as closely with disease activity as did the serum CRP concentration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981476      PMCID: PMC1536622     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

1.  Characterization of IgG complexes in patients with rheumatoid arthritis.

Authors:  R J Winchester
Journal:  Ann N Y Acad Sci       Date:  1975-06-13       Impact factor: 5.691

2.  Complement metabolism in rheumatoid arthritis. I. Longitudinal studies.

Authors:  J M Versey; J R Hobbs; P J Holt
Journal:  Ann Rheum Dis       Date:  1973-11       Impact factor: 19.103

3.  The complement system in rheumatoid synovitis. I. An analysis of complement component activities in rheumatoid synovial fluids.

Authors:  S Ruddy; K F Austen
Journal:  Arthritis Rheum       Date:  1970 Nov-Dec

4.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

5.  C-reactive protein fifty years on.

Authors:  M B Pepys
Journal:  Lancet       Date:  1981-03-21       Impact factor: 79.321

6.  Solid phase radioimmunoassays for human C-reactive protein.

Authors:  B Shine; F C de Beer; M B Pepys
Journal:  Clin Chim Acta       Date:  1981-11-25       Impact factor: 3.786

7.  Comparative clinical study of protein SAP (amyloid P component) and C-reactive protein in serum.

Authors:  M B Pepys; A C Dash; R E Markham; H C Thomas; B D Williams; A Petrie
Journal:  Clin Exp Immunol       Date:  1978-04       Impact factor: 4.330

8.  Analysis of immune complexes in synovial effusions of patients with rheumatoid arthritis.

Authors:  D Male; I M Roitt; F C Hay
Journal:  Clin Exp Immunol       Date:  1980-02       Impact factor: 4.330

9.  The assessment of disease activity in rheumatoid arthritis using a multivariate analysis.

Authors:  R K Mallya; B E Mace
Journal:  Rheumatol Rehabil       Date:  1981-02-01

10.  Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.

Authors:  U E Nydegger; R H Zubler; R Gabay; G Joliat; C H Karagevrekis; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  24 in total

Review 1.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

2.  Modulation of PBMC-decay accelerating factor (PBMC-DAF) and cytokines in rheumatoid arthritis.

Authors:  Roma Pahwa; Uma Kumar; Nibhriti Das
Journal:  Mol Cell Biochem       Date:  2016-02-23       Impact factor: 3.396

3.  Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.

Authors:  V A Makinde; G Senaldi; A S Jawad; H Berry; D Vergani
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

4.  Objective monitoring of disease activity in polyarteritis by measurement of serum C reactive protein concentration.

Authors:  C R Hind; C O Savage; C G Winearls; M B Pepys
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-07

5.  Evaluation of plasma C3d and immune complex determinations in the assessment of disease activity of patients with rheumatoid arthritis, systemic lupus erythematosus, and spondylitis ancylopoetica.

Authors:  P B Krauledat; F E Krapf; B Manger; J R Kalden
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

6.  Comparison of serum and synovial fluid concentrations of beta 2-microglobulin and C reactive protein in relation to clinical disease activity and synovial inflammation in rheumatoid arthritis.

Authors:  M T Walters; F K Stevenson; R Goswami; J L Smith; M I Cawley
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

7.  C-reactive protein levels in patients with rheumatoid arthritis: the impact of therapy.

Authors:  M Tishler; D Caspi; M Yaron
Journal:  Clin Rheumatol       Date:  1985-09       Impact factor: 2.980

8.  The role of genetic variants in CRP in radiographic severity in African Americans with early and established rheumatoid arthritis.

Authors:  M I Danila; A O Westfall; K Raman; L Chen; R J Reynolds; L B Hughes; D K Arnett; G McGwin; A J Szalai; D M van der Heijde; D Conn; L F Callahan; L W Moreland; S L Bridges
Journal:  Genes Immun       Date:  2015-07-30       Impact factor: 2.676

9.  Drug induced impairment of polymorphonuclear cell bactericidal ability in rheumatoid arthritis.

Authors:  P Youinou; P Le Goff
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

10.  C-reactive protein and serological indices of disease activity in systemic lupus erythematosus.

Authors:  J V Bertouch; P J Roberts-Thompson; P H Feng; J Bradley
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.